NTG CLARITY NETWORKS INC (NCI.CA) Stock Fundamental Analysis

TSX-V:NCI • CA62940V2030

1.17 CAD
+0.03 (+2.63%)
Last: Feb 25, 2026, 07:00 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to NCI. NCI was compared to 66 industry peers in the Software industry. NCI has an average financial health and profitability rating. NCI is not priced too expensively while it is growing strongly. Keep and eye on this one! These ratings could make NCI a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • NCI had positive earnings in the past year.
  • NCI had a negative operating cash flow in the past year.
  • NCI had positive earnings in 4 of the past 5 years.
  • NCI had a positive operating cash flow in each of the past 5 years.
NCI.CA Yearly Net Income VS EBIT VS OCF VS FCFNCI.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

1.2 Ratios

  • NCI has a better Return On Assets (17.08%) than 93.94% of its industry peers.
  • NCI's Return On Equity of 28.01% is amongst the best of the industry. NCI outperforms 92.42% of its industry peers.
  • With an excellent Return On Invested Capital value of 23.79%, NCI belongs to the best of the industry, outperforming 95.45% of the companies in the same industry.
Industry RankSector Rank
ROA 17.08%
ROE 28.01%
ROIC 23.79%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NCI.CA Yearly ROA, ROE, ROICNCI.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400

1.3 Margins

  • With an excellent Profit Margin value of 9.85%, NCI belongs to the best of the industry, outperforming 80.30% of the companies in the same industry.
  • NCI's Profit Margin has improved in the last couple of years.
  • NCI has a Operating Margin of 13.86%. This is in the better half of the industry: NCI outperforms 78.79% of its industry peers.
  • In the last couple of years the Operating Margin of NCI has declined.
  • NCI has a Gross Margin of 35.76%. This is in the lower half of the industry: NCI underperforms 62.12% of its industry peers.
  • NCI's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 13.86%
PM (TTM) 9.85%
GM 35.76%
OM growth 3Y-3.27%
OM growth 5YN/A
PM growth 3Y14.92%
PM growth 5YN/A
GM growth 3Y-12.47%
GM growth 5Y7.3%
NCI.CA Yearly Profit, Operating, Gross MarginsNCI.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

6

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so NCI is creating value.
  • Compared to 1 year ago, NCI has more shares outstanding
  • NCI has more shares outstanding than it did 5 years ago.
  • NCI has a better debt/assets ratio than last year.
NCI.CA Yearly Shares OutstandingNCI.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2023 2024 50M 100M
NCI.CA Yearly Total Debt VS Total AssetsNCI.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2023 2024 5M 10M 15M 20M 25M

2.2 Solvency

  • An Altman-Z score of 5.02 indicates that NCI is not in any danger for bankruptcy at the moment.
  • NCI has a better Altman-Z score (5.02) than 78.79% of its industry peers.
  • A Debt/Equity ratio of 0.19 indicates that NCI is not too dependend on debt financing.
  • NCI has a Debt to Equity ratio (0.19) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF N/A
Altman-Z 5.02
ROIC/WACC2.33
WACC10.19%
NCI.CA Yearly LT Debt VS Equity VS FCFNCI.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M -10M

2.3 Liquidity

  • NCI has a Current Ratio of 3.13. This indicates that NCI is financially healthy and has no problem in meeting its short term obligations.
  • NCI's Current ratio of 3.13 is fine compared to the rest of the industry. NCI outperforms 75.76% of its industry peers.
  • NCI has a Quick Ratio of 3.13. This indicates that NCI is financially healthy and has no problem in meeting its short term obligations.
  • NCI has a better Quick ratio (3.13) than 77.27% of its industry peers.
Industry RankSector Rank
Current Ratio 3.13
Quick Ratio 3.13
NCI.CA Yearly Current Assets VS Current LiabilitesNCI.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2023 2024 5M 10M 15M 20M

8

3. Growth

3.1 Past

  • NCI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.26%, which is quite good.
  • The Earnings Per Share has been growing by 68.04% on average over the past years. This is a very strong growth
  • NCI shows a strong growth in Revenue. In the last year, the Revenue has grown by 62.61%.
  • NCI shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 45.43% yearly.
EPS 1Y (TTM)15.26%
EPS 3Y68.04%
EPS 5YN/A
EPS Q2Q%-15.85%
Revenue 1Y (TTM)62.61%
Revenue growth 3Y67.72%
Revenue growth 5Y45.43%
Sales Q2Q%42.22%

3.2 Future

  • Based on estimates for the next years, NCI will show a decrease in Earnings Per Share. The EPS will decrease by -1.23% on average per year.
  • Based on estimates for the next years, NCI will show a very strong growth in Revenue. The Revenue will grow by 31.31% on average per year.
EPS Next Y-34.96%
EPS Next 2Y-1.23%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year46.45%
Revenue Next 2Y31.31%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
NCI.CA Yearly Revenue VS EstimatesNCI.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M
NCI.CA Yearly EPS VS EstimatesNCI.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 0.05 0.1 0.15

6

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 8.36, which indicates a very decent valuation of NCI.
  • Compared to the rest of the industry, the Price/Earnings ratio of NCI indicates a rather cheap valuation: NCI is cheaper than 89.39% of the companies listed in the same industry.
  • When comparing the Price/Earnings ratio of NCI to the average of the S&P500 Index (27.05), we can say NCI is valued rather cheaply.
  • The Price/Forward Earnings ratio is 6.31, which indicates a rather cheap valuation of NCI.
  • Based on the Price/Forward Earnings ratio, NCI is valued cheaply inside the industry as 86.36% of the companies are valued more expensively.
  • NCI is valuated cheaply when we compare the Price/Forward Earnings ratio to 28.03, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 8.36
Fwd PE 6.31
NCI.CA Price Earnings VS Forward Price EarningsNCI.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, NCI is valued cheaper than 83.33% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.54
NCI.CA Per share dataNCI.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5

4.3 Compensation for Growth

  • NCI has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.23%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • NCI does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

NTG CLARITY NETWORKS INC

TSX-V:NCI (2/25/2026, 7:00:00 PM)

1.17

+0.03 (+2.63%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-12
Earnings (Next)N/A
Inst Owners0.35%
Inst Owner ChangeN/A
Ins Owners24.52%
Ins Owner ChangeN/A
Market Cap55.89M
Revenue(TTM)76.65M
Net Income(TTM)7.55M
Analysts84
Price Target4.05 (246.15%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-59.73%
Min EPS beat(2)-85.29%
Max EPS beat(2)-34.18%
EPS beat(4)1
Avg EPS beat(4)-14.44%
Min EPS beat(4)-85.29%
Max EPS beat(4)94.17%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-2.48%
Min Revenue beat(2)-5.69%
Max Revenue beat(2)0.73%
Revenue beat(4)3
Avg Revenue beat(4)1.13%
Min Revenue beat(4)-5.69%
Max Revenue beat(4)8.23%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-33.33%
EPS NY rev (1m)0%
EPS NY rev (3m)-43.75%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.15%
Revenue NY rev (1m)-0.14%
Revenue NY rev (3m)0.61%
Valuation
Industry RankSector Rank
PE 8.36
Fwd PE 6.31
P/S 0.73
P/FCF N/A
P/OCF N/A
P/B 2.07
P/tB 2.39
EV/EBITDA 4.54
EPS(TTM)0.14
EY11.97%
EPS(NY)0.19
Fwd EY15.85%
FCF(TTM)-0.13
FCFYN/A
OCF(TTM)-0.1
OCFYN/A
SpS1.6
BVpS0.56
TBVpS0.49
PEG (NY)N/A
PEG (5Y)N/A
Graham Number1.33
Profitability
Industry RankSector Rank
ROA 17.08%
ROE 28.01%
ROCE 33.04%
ROIC 23.79%
ROICexc 29.91%
ROICexgc 34.7%
OM 13.86%
PM (TTM) 9.85%
GM 35.76%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-3.27%
OM growth 5YN/A
PM growth 3Y14.92%
PM growth 5YN/A
GM growth 3Y-12.47%
GM growth 5Y7.3%
F-Score5
Asset Turnover1.73
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF N/A
Debt/EBITDA 0.43
Cap/Depr 101.9%
Cap/Sales 1.94%
Interest Coverage 31.2
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.13
Quick Ratio 3.13
Altman-Z 5.02
F-Score5
WACC10.19%
ROIC/WACC2.33
Cap/Depr(3y)274.99%
Cap/Depr(5y)720.23%
Cap/Sales(3y)6.12%
Cap/Sales(5y)8.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.26%
EPS 3Y68.04%
EPS 5YN/A
EPS Q2Q%-15.85%
EPS Next Y-34.96%
EPS Next 2Y-1.23%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)62.61%
Revenue growth 3Y67.72%
Revenue growth 5Y45.43%
Sales Q2Q%42.22%
Revenue Next Year46.45%
Revenue Next 2Y31.31%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y53.89%
EBIT growth 3Y62.24%
EBIT growth 5YN/A
EBIT Next Year20.38%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1129.52%
FCF growth 3Y85.08%
FCF growth 5YN/A
OCF growth 1Y-287.68%
OCF growth 3Y12.61%
OCF growth 5Y234.98%

NTG CLARITY NETWORKS INC / NCI.CA FAQ

What is the fundamental rating for NCI stock?

ChartMill assigns a fundamental rating of 6 / 10 to NCI.CA.


What is the valuation status for NCI stock?

ChartMill assigns a valuation rating of 6 / 10 to NTG CLARITY NETWORKS INC (NCI.CA). This can be considered as Fairly Valued.


Can you provide the profitability details for NTG CLARITY NETWORKS INC?

NTG CLARITY NETWORKS INC (NCI.CA) has a profitability rating of 6 / 10.


What is the expected EPS growth for NTG CLARITY NETWORKS INC (NCI.CA) stock?

The Earnings per Share (EPS) of NTG CLARITY NETWORKS INC (NCI.CA) is expected to decline by -34.96% in the next year.